Saturday, September 23, 2023
Saturday, September 23, 2023

Wenzel Spine Announces Leadership Changes

Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive surgical and diagnostic solutions for the treatment of spinal disorders, today announced that its Board of Directors has appointed Dr. Warren Neely as Chairman of the Board and William E. Wilson, President and Chief Executive Officer.

On March 7th, 2022, the unexpected passing of Wenzel Spine’s former President and CEO, Chad G. Neely, left many in the Wenzel Spine community stunned. Dr. Philip Sanger, Managing Partner of TEXO Ventures, said, “We are all going to miss Chad and the presence that he had with company employees, partners, and investors. We are fortunate that Dr. Warren Neely has graciously accepted the position of Chairman of the Board for Wenzel Spine. Dr. Neely is an experienced neurosurgeon who was an early proponent of the VariLift® System and has been actively involved in Wenzel Spine’s development.”

In addition, Wenzel Spine’s Board has appointed William E. (Bill) Wilson as President and Chief Executive Officer of Wenzel Spine. As a founding member of Wenzel Spine, Bill has built his career as an operations management and organizational leader, responsible for the development of the operations, finance, client relations, marketing, strategic partnerships, and medical education teams at Wenzel Spine. Bill’s experience and expertise have enabled him to expertly manage the continuously expanding team and product portfolio. Bill is focused on ensuring that the company’s growth is always centered around Wenzel’s surgeon partners and bringing value to their patients. With Bill’s background in software design and development, Bill can bring a unique perspective to the newest diagnostic solution offering at Wenzel Spine.

TEXO Ventures, Redmont Capital and iNetworks are excited about Bill Wilson assuming his new role as CEO of Wenzel Spine. Bill has been the COO of Wenzel Spine for 13 years and has the experience, knowledge, and vision to take the company forward in a successful manner. “I join our Board of Directors to proudly endorse Bill Wilson as our new CEO, he is the right leader for Wenzel Spine,” said Dr. Warren Neely, Wenzel Spine’s Chairman of the Board. “We are fortunate that Bill and Chad have worked so closely together over the past 13 years. Wenzel Spine is a very strong company, and we plan to continue moving forward in the direction that Chad, Bill, and our Board have always envisioned.”

Commenting on his appointment as CEO, Bill Wilson remarked, “This is a bittersweet transition for us all at Wenzel Spine. I am honored by the request and support of the Board to lead Wenzel Spine into its next chapter of growth and development. Wenzel has some truly innovative products and diagnostic automation technologies in the pipeline to help surgeons and their patients. For Wenzel Spine, our amazing team, and our partners, I am excited about our future.”

Bill holds Bachelor’s degree in Physiology and Computer Science and a Master’s in Computer Science from Michigan State University and his MBA from the University of Texas at Austin.


Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.


Carthera Appoints Dr Oern Stuge as Chairman of Board of Directors

Dr Oern Stuge brings 30+ years expertise with a wealth of experience in product development and commercial launches to support Carthera’s future growth.

Cytomos Appoints a New Director as £4 Mill Investment Sets Path for Commercialisation of Groundbreaking Cell Analysis Technology

The biotech company’s appointment of industry leader Dr Sharon Brownlow as Non-Executive Director further enhances Cytomos’ senior management team and its unique value proposition to key industry markets.

Kindeva Drug Delivery Appoints Brian Schubmehl as Chief Human Resources Officer

Brian Schubmehl brings more than two decades of diverse and senior global leadership expertise that has spanned private equity, startup, and publicly traded organizations.

Joseph Schwab MD, MS, to Lead Spine-Oncology Program and Center for Surgical Technology and AI Research at Cedars-Sinai

Joseph Schwab combines extensive experience in translational research and clinical trials with a record of high-quality clinical care. He specializes in the management of benign and malignant bone tumors as well as spinal disorders, including stenoses and myelopathy. His expertise will drive transformative advancements in spine oncology and surgical technology at Cedars-Sinai.

Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive, Adam Hodges, as Vice President, Sales and Marketing

Adam Hodges brings more than 20 years of commercialization experience in the medical device industry. Most recently, Adam was Vice President of Sales at SIA Health, leading the commercial acceleration of DuraSorb®, which was acquired by Integra LifeSciences (NASDAQ: IART) in December 2022. During his tenure at SIA, Adam grew sales revenue by more than 5X in less than two years and previously served concurrent roles of Vice President of Strategic Accounts and Regional Business Director.

By using this website you agree to accept Medical Device News Magazine Privacy Policy